Table 4:
Absolute and relative increase in signal intensity ratios in subjects who received linear nonionic and linear ionic GBCA in the high-exposure cohorta
| Δ Week –4 to Year 2 |
||||
|---|---|---|---|---|
| Linear Nonionic | P Value | Linear Ionic | P Value | |
| L. DN | 0.08 ± 0.09 (8%) | <.001 | 0.03 ± 0.09 (3%) | .01 |
| L. GP | 0.06 ± 0.06 (6%) | <.001 | 0.02 ± 0.11 (2%) | NS |
| L. CD | 0.03 ± 0.06 (3%) | .03 | 0.03 ± 0.10 (3%) | .04 |
| L. TH | 0.04 ± 0.06 (4%) | .001 | 0.02 ± 0.10 (2%) | NS |
Note:—L. indicates left; NS, not significant.
a
Data are absolute (mean ± SD) and relative (%) increases.